ArticleInternational journal of colorectal disease2026
Application of the Enhanced Recovery After Surgery (ERAS) programme in elective colorectal resection for diverticular disease: a retrospective propensity score-matched cohort study.
Article in International journal of colorectal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiverticular disease is one of the most common benign colorectal conditions and often requires elective resection for recurrent or complicated presentations. Enhanced Recovery After Surgery (ERAS) programmes have demonstrated benefits in mixed colorectal populations; however, evidence in purely benign diverticular cohorts remains limited. This study evaluated the impact of a standardised ERAS pathway on postoperative outcomes following elective colorectal resection for diverticular disease.
methodsThis retrospective multicentre cohort study included consecutive adults undergoing elective left-sided colorectal resection for diverticular disease between 2009 and 2024 in Northern Italy. Patients treated within an ERAS pathway were compared with those receiving conventional care. The primary outcome was length of hospital stay. Secondary outcomes included postoperative morbidity, gastrointestinal recovery, pain, mobilisation, and readmissions. Continuous variables were analysed with the Mann-Whitney U test and categorical variables with χ
resultsA total of 421 patients were included: 329 in the ERAS group and 92 in the non-ERAS group. Baseline characteristics were similar. ERAS adherence was associated with faster gastrointestinal recovery (median time to first flatus: 1 vs 2 days; stool: 1 vs 2 days), lower pain on POD 1 (VAS 2 vs 4), earlier mobilisation (12 h vs 21 h), and earlier solid diet introduction (POD 1 vs POD 2). Overall morbidity was lower in the ERAS group (6.6% vs 14%), without increases in severe complications or readmissions. Median LOS was reduced (4 vs 6 days). Propensity score matching (88 pairs) confirmed these findings.
conclusionERAS implementation in elective colorectal resection for diverticular disease is safe, feasible, and associated with accelerated recovery, reduced morbidity, and shorter hospital stay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.